5F-MDMB-PICA
5F-MDMB-PICA is a designer drug and synthetic cannabinoid. In 2018, it was the fifth-most common synthetic cannabinoid identified in drugs seized by the Drug Enforcement Administration. 5F-MDMB-PICA is a potent agonist of both the CB1 receptor and the CB2 receptor with EC50 values of 0.45 nM and 7.4 nM, respectively. In the United States, 5F-MDMB-PICA was temporarily emergency scheduled by the DEA in 2019. In December 2019, the UNODC announced scheduling recommendations placing 5F-MDMB-PICA into Schedule II. In the United States 5F-MDMB-PICA was made a permanent Schedule I Controlled Substance This is the list of Schedule I drugs as defined by the United States Controlled Substances Act. 21 CFRbr>1308.11(CSA Sched I) with changes through (Oct 18, 2012). Retrieved September 6, 2013. The following findings are required for drugs to be pla ... nationwide on April 7, 2022. References Further reading * {{Cannabinoids Cannabinoids Designer drugs Indolecarb ...
[...More Info...]       [...Related Items...]     OR:     [Wikipedia]   [Google]   [Baidu]